Gatehouse Bio

About:

biotech company developing effective therapeutics using AI that harnesses the power of small RNA

Website: https://www.gatehousebio.com

Top Investors: IndieBio, SOSV, Front Row Fund

Description:

Gatehouse Bio is a biotech company developing effective therapeutics using AI that harnesses the power of small RNA. Their platform discovers disease-associated mutations and designs therapeutics to counteract their effect. We believe there is an RNA code that can treat every disease Our mission is to find that code and use it to develop effective therapeutics Our platform uses AI to discover mutations in small RNA genes and design oligonucleotides that crack a disease’s code Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity (Fibrosis, Inflammation, Neurodegeneration) With every single code we break, we unlock the potential to improve the lives of many

Total Funding Amount:

$7.95M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Natick, Massachusetts, United States

Founded Date:

2018-04-16

Contact Email:

neal.foster(AT)gatehousebio.com

Founders:

David Salzman, Neal Foster

Number of Employees:

11-50

Last Funding Date:

2024-09-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai